About Sofia Bio
Sofia Bio is a company based in Sofia (Bulgaria) founded in 2005 was acquired by Discovery Life Sciences in February 2019. Sofia Bio operates in a competitive market with competitors including Sapien Biosciences, Shivom, Reprotech, Gen-t and BioSEND, among others.
- Headquarter Sofia, Bulgaria
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sofiabio.com
- Social LinkedIn
- Acquired by Discovery Life Sciences (Feb 2019)
- Investors
- Acquired byDiscovery Life Sciences
(Feb 2019)
Investors in Sofia Bio
Sofia Bio has secured backing from 1 investor. Prominent investors backing the company include Discovery Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of diversified services with integrated technology platforms for drug discovery | 2006 | dls.com | Huntsville, United States |
Investor details for Sofia Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sofia Bio
2 dated milestones of Sofia Bio across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Sofia Bio is founded.
- Exit Acquired by Discovery Life Sciences.
Competitors of Sofia Bio
Sofia Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sapien Biosciences, Shivom, Reprotech, Gen-t and BioSEND, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sapienbio.co.in | 2012 | Hyderabad, India | – | 38 | Biobanking services are offered for biomarker discovery and drug development. | |
| shivom.io | 2017 | Chandigarh, India | – | 3 | Blockchain-based genomics and data discovery platform is provided. | |
| reprotech.com | 1990 | Coconut Creek, United States | – | – | Provider of cryostorage and cryobank facilities for reproductive tissues | |
| gen-t.science | 2021 | Sao Paulo, Brazil | $1.94M | – | Gene bio-bank services are provided to support precision medicine acceleration. | |
| biosend.org | 2015 | United States | – | – | A platform for secure storage and management of biological samples and associated data. | |
| dnaliveforever.com | 2010 | Tampa, United States | – | – | Delivers comprehensive solutions for gene biobanking and storage services. |
Detailed competitors of Sofia Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sofia Bio
Complete news archive for Sofia Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sofia Bio
10 companies that operate in the same segment as Sofia Bio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sofia Bio
Sofia Bio was founded in 2005.
Sofia Bio is headquartered in Sofia, Bulgaria.
Sofia Bio offers customized tissue procurement services for biopharmaceutical firms. They offer human tissue procurement services in the therapeutic field including solid tumors, hematological malignancies, biological fluids, inflammatory diseases, and metabolic disorders.
Sofia Bio's top competitors include Sapien Biosciences, Shivom and Gen-t.
Sofia Bio has 1 investor. Key investors include Discovery Life Sciences.
Yes. Sofia Bio was acquired by Discovery Life Sciences in February 2019.